Brensocatib Recruiting Phase 2 Trials for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT06013241
A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)